Related Experiment Video
Updated: Apr 11, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
32.7K
Bronchial thermoplasty in asthma: current perspectives
Balaji Laxmanan1, D Kyle Hogarth1
1Section of Pulmonary and Critical Care Medicine, University of Chicago Medicine, Chicago, IL, USA.
Journal of Asthma and Allergy
|June 2, 2015
Summary
Bronchial thermoplasty (BT) offers a novel treatment for severe asthma by reducing airway smooth muscle. Clinical trials show BT improves quality of life and reduces asthma exacerbations, with demonstrated long-term safety and effectiveness.
Area of Science:
- Pulmonary Medicine
- Interventional Pulmonology
- Asthma Therapeutics
Background:
- Severe asthma management remains challenging.
- Bronchial thermoplasty (BT) is an emerging therapy targeting airway hyperresponsiveness.
- Understanding BT's long-term impact is crucial.
Purpose of the Study:
- To evaluate the efficacy and safety of bronchial thermoplasty in severe asthma.
- To assess long-term outcomes including exacerbations and quality of life.
- To identify patient subgroups benefiting most from BT.
Main Methods:
- Review of clinical trials investigating bronchial thermoplasty.
- Analysis of radiofrequency thermal energy application to reduce airway smooth muscle mass.
- Assessment of asthma-related quality of life and exacerbation rates.
Main Results:
- Bronchial thermoplasty demonstrates significant improvements in asthma-related quality of life.
- BT treatment leads to a reduction in the number of asthma exacerbations.
- Long-term data indicate sustained benefits and safety of the procedure.
Conclusions:
- Bronchial thermoplasty is a safe and effective treatment option for severe asthma.
- Further research is needed to understand BT's mechanisms of action.
- Characterizing asthma subphenotypes will optimize BT's role in clinical practice.
More Related Videos
Related Concept Videos
01:24Chest Physiotherapy
2.7K
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
2.7K
01:20Asthma: Pathogenesis and Management
1.7K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
1.2K
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
01:17Drugs Used in Lower Respiratory Disorders: Overview
1.6K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.6K
01:26Asthma-II: Pathophysiology and Classification
5.0K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
5.0K